1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 43 Hits
  • Search Condition : Filter (MeSH = Breast Neoplasms / pathology)
Species Resource
DNA material pKM2L-phUPA p1966-9F (RDB05547) Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer.
Drosophila DGRC#125903 FAK acts as a suppressor of RTK-MAP kinase signalling in Drosophila melanogaster epithelia and human cancer cells.
C.elegans tm1095 Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation.
DNA material pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393). Reversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system.
Silkworms Niemann-Pick disease type C2 protein induces autophagy and inhibits growth in FM3A breast cancer cells.
DNA material pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) , CSII-CMV-MCS-IRES2-Bsd (RDB04385). Live-cell imaging visualizes frequent mitotic skipping during senescence-like growth arrest in mammary carcinoma cells exposed to ionizing radiation.
Human and Animal Cells MCF7(RCB1904) Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7.
Human and Animal Cells MDA-MB-453(RCB1192) Actinin-1 and actinin-4 play essential but distinct roles in invadopodia formation by carcinoma cells.
Human and Animal Cells MCF7(RCB1904) Subcellular Localization of Maspin Correlates with Histone Deacetylase 1 Expression in Human Breast Cancer.
Human and Animal Cells MCF7(RCB1904) TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Human and Animal Cells SAS(RCB1974) Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models.
Human and Animal Cells Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Human and Animal Cells Combination of the mTOR inhibitor ridaforolimus and the anti-IGF1R monoclonal antibody dalotuzumab: preclinical characterization and phase I clinical trial.
Human and Animal Cells The single N-glycan deletion mutant of soluble ErbB3 protein attenuates heregulin β1-induced tumor progression by blocking of the HIF-1 and Nrf2 pathway.
Human and Animal Cells MCF7(RCB1904) The HSF1-PARP13-PARP1 complex facilitates DNA repair and promotes mammary tumorigenesis.
Human and Animal Cells MCF7(RCB1904) , MDA-MB-453(RCB1192) , RAW 264(RCB0535) A-Disintegrin and Metalloproteinase (ADAM) 17 Enzymatically Degrades Interferon-gamma.
Human and Animal Cells MCF7(RCB1904) Deficiency of X-Linked Protein Kinase Nrk during Pregnancy Triggers Breast Tumor in Mice.
Human and Animal Cells MDA-MB-453(RCB1192) , MCF7(RCB1904) Transcriptional repression of HER2 by ANO1 Cl- channel inhibition in human breast cancer cells with resistance to trastuzumab.
Human and Animal Cells MDA-MB-453(RCB1192) , MCF7(RCB1904) Down-Regulation of Ca2+-Activated K⁺ Channel KCa1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor Agonists.
Human and Animal Cells MCF7(RCB1904) The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.